Associate Professor of Physical Medicine & Rehabilitation, Johns Hopkins School of Medicine
Associate Professor of Pediatrics, Johns Hopkins School of Medicine
Associate Director of Rehabilitation, Kennedy Krieger Institute Dr. Pidcock joined the Johns Hopkins PM&R faculty in 1994 after completing residency training in Pediatrics, Developmental Pediatrics, and Physical Medicine & Rehabilitation. Dr. Pidcock is a graduate of Hahnemann Medical College (1977). He earned his undergraduate degree in Natural Sciences at the Johns Hopkins University (1973). His clinical interests include the use of botulinum toxin injections to treat children with spasticity and the development of constraint induced therapies to improve the use of hemiparetic upper limbs. Other areas of interest for Dr. Pidcock include the rehabilitation of children with pediatric transverse myelitis and chronic graft vs. host disease. Dr. Pidcock is a member of the Transverse Myelitis Association Medical Advisory Board. He is an examiner for the American Board of Physical Medicine & Rehabilitation oral examinations. He is a member of American Academy of Physical Medicine and Rehabilitation and the American Academy of Cerebral Palsy and Developmental Medicine. Education: - 1973 B.A. with academic honors, The Johns Hopkins University
- 1977 M.D. Hahnemann Medical College
Faculty Appointments: - Associate Professor of Physical Medicine & Rehabilitation,
The Johns Hopkins University School of Medicine
- Associate Professor of Pediatrics, The Johns Hopkins University School of Medicine
Hospital and Administrative Appointments: - Associate Director of Pediatric Rehabilitation, Kennedy Krieger Institute
- Medical Director, Specialized Transition Programs, Kennedy Krieger Institute
- Active Staff, Johns Hopkins Hospital, Baltimore, MD
- Active Staff, Kennedy Krieger Children’s Hospital, Baltimore, MD
- Director of training program in Pediatric Rehabilitation Medicine, Johns Hopkins University School of Medicine/Kennedy Krieger Institute
Specialty Certifications: - American Board of Pediatrics
- American Board of Physical Medicine and Rehabilitation
- American Board of Physical Medicine and Rehabilitation, Subspecialty Certification in Pediatrics
Honors: - Phi Beta Kappa, The Johns Hopkins University
- The Johns Hopkins University Seal for “Outstanding Service to the University”
- United Cerebral Palsy Clinical Fellow in Pediatrics, St. Christopher’s Hospital for Children, Philadelphia, PA
- Achievement Award in the Category of Patient Care, The Hospital Association of Pennsylvania
- Achievement Award in the Category of Patient Education, The Hospital Association of Pennsylvania
- Traveling Fellow for Japanese Association of Rehabilitation Medicine
Representative Publications:
Pidcock FS, Graziani LJ, Stanley C, Mitchell DG, Merton D: Neurosonographic Features of Periventricular Echodensities Associated with Cerebral Palsy in Preterm Infants. Journal of Pediatrics 1990; 116(3):417-422 Pidcock FS, Hoon A, Johnston MV: Trihexyphenidyl in Posthemorrhagic Dystonia: Motor and Language Effects. Pediatric Neurology 1999; 20:219-222 Pidcock FS, Wise JM, Christensen JR: Treatment of Severe Post-Traumatic Bruxism with Botulinum Toxin-A: Case Report. Journal of Oral and Maxillofacial Surgery 2002; 60: 117-120 Pidcock FS, Fauerbach JA, Ober M, Carney J. The Rehabilitation/School Matrix: A model for accommodating the noncompliant child with severe burns. Journal of Burn Care & Rehabilitation 2003; 24: 342-346 Kanda T, Pidcock FS, Hayakawa K, Yamori Y, Shikata Y. Motor outcome differences between two groups of children with spastic diplegia who received different intensities of early onset physiotherapy followed for five years. Brain & Development 2004; 26: 118-1126. Pidcock FS. The emerging role of therapeutic botulinum toxin in the treatment of cerebral palsy. J Pediatr. 2004 Aug;145(2 Suppl):S33-5. Pidcock FS, Fish DE, Johnson-Greene D, Borras I, Mc Gready J, Silberstein CE. Hip Migration Percentage in Children with Cerebral Palsy Treated with Botulinum Neurotoxin Type A. Arch PM&R. 2005; 86(3):431-435. Pidcock FS. Botulinum toxin type A treatment in neurogenetic syndromes. Pediatric Rehabilitation. 2005 October; 8(4): 298-302. Current Address: KennedyKriegerInstitute
707 North Broadway
Baltimore , MD 21205 USA Phone: 443-923-9440
Fax: 443-923-9445
Email: Pidcock@kennedykrieger.org |
